MP
LFST icon

Mangrove Partners’s Lifestance Health LFST Stock Holding History

Mangrove Partners’s Portfolio LFST Stock Details LFST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$712K Sell
66,466
-121,244
-65% -$937K 0.05% 164
2026
Q1 		$1.2M Buy
+187,710
New +$1.31M 0.1% 107

Other funds holding LFST

TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SP
Summit Partners Boston, Massachusetts $609M AUM 7.66% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Mangrove Partners's LFST Position: Q2 2026 in Review

Mangrove Partners reduced its Lifestance Health (LFST) stake by 65% in Q2 2026, selling an estimated $937K and leaving 66,466 shares worth $712K. The position accounts for 0.05% of the portfolio, ranked #164.

Mangrove Partners first reported a position in LFST in Q1 2026 and has held it in 2 quarters since. The position peaked at $1.2M in Q1 2026. 287 funds tracked by Wall St. Rank hold LFST as of Q2 2026.

  • Mangrove Partners held 66,466 shares of Lifestance Health worth $712K as of Q2 2026.
  • Mangrove Partners sold 121,244 Lifestance Health shares in Q2 2026, an estimated $937K.
  • Lifestance Health made up 0.05% of Mangrove Partners's portfolio in Q2 2026, its #164 holding.
  • Mangrove Partners first reported a position in Lifestance Health in Q1 2026 and has held it in 2 quarters since.
  • Mangrove Partners's Lifestance Health position peaked at $1.2M in Q1 2026.
  • 287 funds tracked by Wall St. Rank held Lifestance Health as of Q2 2026.

Based on Mangrove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.